CMR Surgical

Develops and sells the Versius modular surgical robotic system for minimal access surgery.

View on the globe

$600MEquity raised in 2025–20262025 $200M · 2026 $400M · 2 equity rounds
$1.6BEquity raised, all time5 equity rounds sourced so far
$3BLatest valuationpost-money, as reported

Rounds over time log-scaled amounts

Funding history: 5 rounds from 17 Sep 2019 to 12 Oct 2026, $1.6B equity disclosed, latest valuation $3B. Earlier rounds exist but are not sourced.17 Sep 2019: Series C, $240M; 28 Jun 2021: Series D, $600M, valued at $3B; 20 Sep 2023: Funding round, $165M; 2 Apr 2025: Equity and debt financing, $200M; 12 Oct 2026: Strategic preferred equity investment, $400M$100M$300M$1B$3B$10BEarlier rounds exist but are not sourced yet← earlier rounds not sourcedest. 201420202021202220232024202520262027Equity roundPost-money valuation28 Jun 2021 · Series D · valued at $3B28 Jun 2021 · Series D · $600M at $3B · led by SoftBank, Ally Bridge Group12 Oct 2026 · Strategic preferred equity investment · $400M · led by Stryker17 Sep 2019 · Series C · $240M2 Apr 2025 · Equity and debt financing · $200M20 Sep 2023 · Funding round · $165M · led by Ally Bridge Group, Cambridge Innovation Capital, Escala Capital$3BSeries D · $600MStrategic · $400MSeries C · $240MOther · $200MVenture · $165M
Funding history: 5 rounds from 17 Sep 2019 to 12 Oct 2026, $1.6B equity disclosed, latest valuation $3B. Earlier rounds exist but are not sourced.17 Sep 2019: Series C, $240M; 28 Jun 2021: Series D, $600M, valued at $3B; 20 Sep 2023: Funding round, $165M; 2 Apr 2025: Equity and debt financing, $200M; 12 Oct 2026: Strategic preferred equity investment, $400M$100M$300M$1B$3B$10BEarlier rounds exist but are not sourced yetearlier rounds not sourced’142021202320252027Equity roundValuation28 Jun 2021 · Series D · valued at $3B28 Jun 2021 · Series D · $600M at $3B · led by SoftBank, Ally Bridge Group12 Oct 2026 · Strategic preferred equity investment · $400M · led by Stryker17 Sep 2019 · Series C · $240M2 Apr 2025 · Equity and debt financing · $200M20 Sep 2023 · Funding round · $165M · led by Ally Bridge Group, Cambridge Innovation Capital, Escala Capital$3B$600M$400M$240M$200M$165M

Funding history 5 rounds · 5 sources · newest first

Earlier rounds not yet sourced. CMR Surgical was founded in 2014 and raised before 17 Sep 2019; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Strategic preferred equity investment
    Amount$400MGBP 300M
    Post-money—
    ✓ Confirmed
    Lead
    Stryker
    Note
    About $400M (GBP 300M) preferred equity, subject to regulatory approvals and closing conditions. Stryker also gets an exclusive right to acquire the remaining equity later; valuation not disclosed.
    Sources
  2. Equity and debt financing
    Amount$200M
    Post-money—
    ✓ Confirmed
    Also
    Trinity Capital
    Note
    More than $200M combining equity and debt; the split was not disclosed, so it is kept as one entry. Backed by all existing major investors; Trinity Capital provided new debt.
    Sources
  3. Funding round
    Amount$165MGBP 133M
    Post-money—
    ✓ Confirmed
    Lead
    Ally Bridge Group, Cambridge Innovation Capital, Escala Capital, LGT, Lightrock, Railpen, SoftBank, Tencent, Watrium
    Note
    Led by all major existing investors; upsized on internal demand. Round type not specified.
    Sources
  4. Series D
    Amount$600M
    Post-money$3B
    ✓ Confirmed
    Lead
    SoftBank, Ally Bridge Group
    Also
    Railpen, Tencent, Chimera, LGT, Lightrock, Watrium, Cambridge Innovation Capital, PFM Health Sciences, GE Healthcare
    Note
    GBP 425M announced. The $3B valuation is quoted by the then-CEO.
    Sources
  5. Series C
    Amount$240MGBP 195M
    Post-money—
    ✓ Confirmed
    Also
    LGT, Escala Capital, Cambridge Innovation Capital, Watrium, Zhejiang Silk Road Fund
    Note
    Existing investors plus new unnamed US investors.
    Sources
  6. Earlier rounds not yet sourced

Investors 15

  • Cambridge Innovation Capital3
  • LGT3
  • Watrium3
  • Ally Bridge Group2
  • Escala Capital2
  • Lightrock2
  • Railpen2
  • SoftBank2
  • Tencent2
  • Stryker1
  • Chimera
  • GE Healthcare
  • PFM Health Sciences
  • Trinity Capital
  • Zhejiang Silk Road Fund

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Also in the Cambridge hub see on the globe

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. CMR Surgical and its logo are trademarks of their owners, used here for identification only.